<DOC>
	<DOC>NCT02111473</DOC>
	<brief_summary>The study is designed to answer the following questions: 1) What is the effect of testosteron replacement treatment on the endothelial dysfunction. 2/ What is the effect of testosteron replacement on the bone mineral metabolism.</brief_summary>
	<brief_title>The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism</brief_title>
	<detailed_description>this is an interventional study which is examine the effect of testosteron replacement treatment on the endothelial dysfunction and bone mineral metabolism in hypogonadotropic hypogonadal patients.</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<mesh_term>N,N-dimethylarginine</mesh_term>
	<criteria>Men Congenital hypogonadism Treatment Naive Previous history of androgen replacement Hypertension Diabetes mellitus</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>28 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>endothelial dysfunction</keyword>
	<keyword>bone mineral metabolism</keyword>
	<keyword>testosteron replacement treatment</keyword>
</DOC>